Biogen Idec (BIIB)

Add to Watchlists Create an Alert
235.24 +2.62  +1.13%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Biogen Idec Cash from Financing TTM:

-699.64M for March 31, 2013
View Full Chart

Biogen Idec Cash from Financing TTM Chart

    Biogen Idec Historical Cash from Financing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -699.64M
    Dec. 31, 2012 -877.48M
    Sept. 30, 2012 -1.005B
    June 30, 2012 -1.076B
    March 31, 2012 -636.29M
    Dec. 31, 2011 -319.86M
    Sept. 30, 2011 48.87M
    June 30, 2011 -313.26M
    March 31, 2011 -1.361B
       
    Dec. 31, 2010 -1.785B
    Sept. 30, 2010 -2.678B
    June 30, 2010 -2.210B
    March 31, 2010 -1.181B
    Dec. 31, 2009 -724.15M
    Sept. 30, 2009 -389.19M
    June 30, 2009 -260.74M
    March 31, 2009 -514.02M
    Dec. 31, 2008 -1.235B

    About Cash From Financing (TTM)

    Definition: Cash from Financing

    Learn More

    Get data for

    BIIB Cash from Financing TTM Benchmarks

    Companies
    Elan -190.20M
    Novartis -8.273B
    Celgene Corporation -592.13M

    BIIB Cash from Financing TTM Rankings

    Overall 40th percentile
    4773 of 8011
    Sector 17th percentile
    568 of 687 in Healthcare
    Industry 17th percentile
    205 of 248 in Biotechnology

    BIIB Cash from Financing TTM Range, Past 5 Years

    Minimum -2.678B Sep 2010
    Maximum 48.87M Sep 2011
    Average -956.40M